<DOC>
	<DOCNO>NCT02415062</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy high-dose donepezil ( 23mg ) Parkinson 's disease dementia compare standard dose donepezil .</brief_summary>
	<brief_title>The Efficacy Safety Study High Dose Donepezil Parkinson 's Disease With Dementia</brief_title>
	<detailed_description>This study open-label , prospective , randomize parallel study . The investigator evaluate efficacy high-dose donepezil patient Parkinson 's disease dementia ( PDD ) take standard donepezil ( 10mg ) 12 week . The participant , sign informed consent , assign two group randomly ( high-dose donepezil group standard donepezil group ) . All participant maintain medication 24 week assess cognitive function 24 week . They visit clinic 3 time ( 4 , 12 , 24 week ) assess cognitive function adverse event . After end study , participant administrate standard dose donepezil .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criterion : Patients diagnose Parkinson 's disease accord Queen Brain Bank criterion Patients diagnose dementia diagnose Parkinson 's disease least 1 year . Patients Hoehn Yahr stag 2 4 Patients MMSE score 10 24 Patients take donepezil least 12 week screen period Patients whose medication Parkinson 's disease change 1 month Patients give informed consent Exclusion criterion : Patients perform neuropsychiatric test hear visual difficulty Patients take medicine affect cognitive function anticholinergic drug memantine Patients diagnose dementia Lewy body vascular dementia Patients history neurosyphilis , head trauma , encephalitis movement disorder Patients psychiatric disease Except patient stable state antidepressant atypical neuroleptic Patients childbearing period Patients severe liver kidney disease necessary aggressive treatment Patients gastrointestinal disease need treatment Patients take tablet per oral Patients participate clinical trial except observational study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>dementia</keyword>
</DOC>